# A Rare Presentation of Lymph Node Metastasis of VIPoma After Three Years of Resection: A Case Report

**Authors:** Oğuzhan Şal, Katsunori Sakamoto, Kei Tamura, Masahiko Honjo, Yusuke Nishi, Takahiro Hikida, Akimasa Sakamoto, Naotake Funamizu, Kohei Ogawa, Yasutsugu Takada

PMC · DOI: 10.7759/cureus.57628 · Cureus · 2024-04-04

## TL;DR

This case report describes the rare occurrence of lymph node metastasis in a patient with VIPoma three years after tumor resection.

## Contribution

This is the first reported case of metachronous lymph node metastasis in a patient with previously resected VIPoma.

## Key findings

- Lymph node metastasis was detected three years after successful VIPoma resection.
- Lymphadenectomy was performed successfully with no significant complications.
- The case highlights the need for close follow-up to prevent recurrence in VIPoma patients.

## Abstract

Vasoactive intestinal peptide-producing tumor of the pancreas (VIPoma) is one of the rarer subtypes of neuroendocrine tumor (NET) of the pancreas. It usually represents intractable diarrhea, weight loss, and electrolyte abnormalities secondary to diarrhea. The most common site of metastasis of VIPoma is the liver. Furthermore, lymph node metastasis (LNM) is rare, and no metachronous LNM with a resectable situation has been reported before. A 60-year-old male patient (height: 181 cm, body weight: 74 kg) with a history of operated pancreatic VIPoma three years ago was referred to our department due to the detection of lymphadenomegaly which was suggestive of lymph node metastasis by routine follow-up computed tomography (CT). Preoperative CT showed a lymph node on the left side of the abdominal aorta and caudal side of the left renal vein with a size of 1 cm. Lymphadenectomy was performed without significant complications and blood loss. This is the first report of metachronous LNM in a patient with operated VIPoma. Although much rarer than solid organ metastasis of VIPoma, LNM in these patients can also be seen synchronously and metachronously. Close follow-up and vigilance are key to preventing recurrence-related morbidity and mortality in these patients.

## Linked entities

- **Diseases:** VIPoma (MONDO:0019960), neuroendocrine tumor (MONDO:0019496)

## Full-text entities

- **Diseases:** electrolyte abnormalities (MESH:D014883), LNM (MESH:D008207), weight loss (MESH:D015431), VIPoma (MESH:D003969), diarrhea (MESH:D003967), metastasis (MESH:D009362), of the pancreas (MESH:D010190), blood loss (MESH:D016063), NET (MESH:D018358)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11070202/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11070202/full.md

## References

9 references — full list in the complete paper: https://tomesphere.com/paper/PMC11070202/full.md

---
Source: https://tomesphere.com/paper/PMC11070202